These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 30738960)

  • 1. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
    Feng LL; Shen FR; Zhou JH; Chen YG
    Gene; 2019 May; 696():105-112. PubMed ID: 30738960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer.
    Wang W; Xing C
    Pathol Res Pract; 2016 Aug; 212(8):690-5. PubMed ID: 27461828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
    Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
    Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
    Zhang WY; Liu YJ; He Y; Chen P
    J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression.
    Pan L; Liang W; Fu M; Huang ZH; Li X; Zhang W; Zhang P; Qian H; Jiang PC; Xu WR; Zhang X
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):991-1004. PubMed ID: 28285404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation and hypomethylation of lncRNA AFAP1‑AS1 predicts a poor prognosis and promotes the migration and invasion of cervical cancer.
    Bo H; Fan L; Gong Z; Liu Z; Shi L; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li G; Xiong W; Zeng Z; Cao K; Zhang S; Xiong F
    Oncol Rep; 2019 Apr; 41(4):2431-2439. PubMed ID: 30816545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long noncoding RNA ZFAS1 facilitates bladder cancer tumorigenesis by sponging miR-329.
    Wang JS; Liu QH; Cheng XH; Zhang WY; Jin YC
    Biomed Pharmacother; 2018 Jul; 103():174-181. PubMed ID: 29653362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZFAS1 knockdown inhibits viability and enhances cisplatin cytotoxicity by up-regulating miR-432-5p in glioma cells.
    Yang G; Han B; Feng T
    Basic Clin Pharmacol Toxicol; 2019 Dec; 125(6):518-526. PubMed ID: 31246330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21.
    Yao T; Lu R; Zhang J; Fang X; Fan L; Huang C; Lin R; Lin Z
    J Cell Physiol; 2019 Jun; 234(6):9605-9615. PubMed ID: 30352127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with Poor Patient Prognosis.
    Iden M; Fye S; Li K; Chowdhury T; Ramchandran R; Rader JS
    PLoS One; 2016; 11(5):e0156274. PubMed ID: 27232880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients.
    Xu QF; Tang YX; Wang X
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4440-4447. PubMed ID: 30058681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
    Zhou ZP; Wang LP; Hong ZS; Qiu CZ; Wang MZ; Chen ZX; Tang LF; Yu WS; Wang CX
    Int J Oncol; 2018 Sep; 53(3):1183-1192. PubMed ID: 30015866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-1284 enhances sensitivity of cervical cancer cells to cisplatin via downregulating HMGB1.
    Chen J; Li G
    Biomed Pharmacother; 2018 Nov; 107():997-1003. PubMed ID: 30257412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MEG3 has anti-activity effects of cervical cancer.
    Wang X; Wang Z; Wang J; Wang Y; Liu L; Xu X
    Biomed Pharmacother; 2017 Oct; 94():636-643. PubMed ID: 28787698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Long Noncoding RNA CRNDE Increases Chemosensitivity of Medulloblastoma Cells by Targeting miR-29c-3p.
    Sun XH; Fan WJ; An ZJ; Sun Y
    Oncol Res; 2020 Feb; 28(1):95-102. PubMed ID: 31753063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA CRNDE acts as an oncogene in cervical cancer through sponging miR-183 to regulate CCNB1 expression.
    Bai X; Wang W; Zhao P; Wen J; Guo X; Shen T; Shen J; Yang X
    Carcinogenesis; 2020 Mar; 41(1):111-121. PubMed ID: 31605132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA HOTAIR and STAT3 synergistically regulate the cervical cancer cell migration and invasion.
    Zhang Y; Cheng X; Liang H; Jin Z
    Chem Biol Interact; 2018 Apr; 286():106-110. PubMed ID: 29572071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing CDR1as enhances the sensitivity of breast cancer cells to drug resistance by acting as a miR-7 sponge to down-regulate REGγ.
    Yang W; Yang X; Wang X; Gu J; Zhou D; Wang Y; Yin B; Guo J; Zhou M
    J Cell Mol Med; 2019 Aug; 23(8):4921-4932. PubMed ID: 31245927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
    Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.